ABT
Abbott LaboratoriesNYSE
Healthcare • Medical Devices
Factor tilt: Large-Cap Blend
$109.93-3.23%
Close Nov 6, 2026
- Market cap
- $191.61B
- 1 month
- +11.6%
- 3 months
- +1.2%
- 1 year
- -11.7%
- 52-week range
- $82.56$130.59
- Dividend, last 12 mo
- $2.52 · 2.29% yield
- Last ex-date
- Oct 15, 2026 · $0.63
- Dividend growth
- 12 years in a row
- Short interest
- 1.0% of float17.4M shares · settled Oct 15, 2026 · +27.5% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Sep 30, 2026
- Revenue
- $48.23B
- Net income
- $4.7B
- Free cash flow
- $7.65B
- Book value
- $51.03B
- Total debt
- $31.16B
- P/E
- 40.8×
- Price / sales
- 4×
- Price / book
- 3.8×
- FCF yield
- +4.0%
- Net margin
- +9.7%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Read more
The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
- Website
- abbott.com
- Headquarters
- Abbott Park, IL, United States
- Employees
- 122,000
- Listed
- Jan 13, 1978
- Fiscal year ends
- December
Company profile from EODHD, stored Nov 7, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2026filed Nov 4, 2026 | $13.0B | +14.5% | 57.1% | $1.5B | $920.0M |
| Jun 2026filed Jul 28, 2026 | $12.6B | +13.0% | 58.0% | $1.8B | $928.0M |
| Mar 2026filed Apr 29, 2026 | $11.2B | +7.8% | 56.3% | $1.8B | $1.1B |
| Dec 2025filed Feb 20, 2026 | $11.5B | +4.4% | 57.0% | $2.3B | $1.8B |
| Sep 2025filed Oct 29, 2025 | $11.4B | +6.9% | 55.7% | $2.1B | $1.6B |
| Jun 2025filed Jul 30, 2025 | $11.1B | +7.4% | 56.4% | $2.1B | $1.8B |
| Mar 2025filed Apr 30, 2025 | $10.4B | +4.0% | 52.6% | $1.7B | $1.3B |
| Dec 2024filed Feb 21, 2025 | $11.0B | +7.2% | 51.0% | $2.0B | $9.2B |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Feb 20, 2026 | $44.3B | +5.7% | 55.5% | $8.0B | $6.5B |
| Dec 2024filed Feb 21, 2025 | $42.0B | +4.6% | 50.8% | $6.8B | $13.4B |
| Dec 2023filed Feb 16, 2024 | $40.1B | -8.1% | 50.0% | $6.4B | $5.7B |
| Dec 2022filed Feb 17, 2023 | $43.7B | +1.3% | 51.1% | $8.4B | $6.9B |
| Dec 2021filed Feb 18, 2022 | $43.1B | +24.5% | 53.9% | $9.2B | $7.1B |
| Dec 2020filed Feb 19, 2021 | $34.6B | +8.5% | 50.2% | $5.3B | $4.5B |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched ABT. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
17,386,736 shares short
+3,752,480 shares (+27.5%) vs Sep 30, 2026
1% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
13,634,256 shares short
-6,276,943 shares (-31.5%) vs Sep 15, 2026
0.8% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
19,911,199 shares short
-2,218,551 shares (-10%) vs Aug 31, 2026
Share of float unavailable. Published Sep 24, 2026.
Settlement Aug 31, 2026
22,129,750 shares short
+1,754,617 shares (+8.6%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
20,375,133 shares short
-2,249,051 shares (-9.9%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
22,624,184 shares short
-2,221,963 shares (-8.9%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind ABT’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
USD 0.63 per share
Ex-dividend date: Oct 15, 2026
Recorded pay date: Nov 16, 2026 (pending)
Cash dividend · Polygon event record
USD 0.63 per share
Ex-dividend date: Jul 15, 2026
Recorded pay date: Aug 17, 2026 (past date)
Cash dividend · Polygon event record
USD 0.63 per share
Ex-dividend date: Apr 15, 2026
Recorded pay date: May 15, 2026 (past date)
Cash dividend · Polygon event record
USD 0.63 per share
Ex-dividend date: Jan 15, 2026
Recorded pay date: Feb 13, 2026 (past date)
Cash dividend · Polygon event record
USD 0.59 per share
Ex-dividend date: Oct 15, 2025
Recorded pay date: Nov 17, 2025 (past date)
Cash dividend · Polygon event record
USD 0.59 per share
Ex-dividend date: Jul 15, 2025
Recorded pay date: Aug 15, 2025 (past date)
Cash dividend · Polygon event record
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
5000 for 2399 · forward split
Effective Jan 2, 2013
Each 2399 pre-split shares become 5000 post-split shares.
Source: EODHD
2500 for 2339 · forward split
Effective May 3, 2004
Each 2339 pre-split shares become 2500 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Jun 1, 1998
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Jun 1, 1992
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Jun 1, 1990
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Jun 2, 1986
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if ABT is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
316 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Nov 6, 2026
Smart-money 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bearish
Last trade: sell 1 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 1
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
2,997 filers reported a long position in ABT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
44.8%
of the 1.4B shares 13-F filers reported
Moves vs Q1 2026
6 added3 trimmed
1 not comparable
Net shares held
+0.9%
across the 9 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $13.8B · 152.6M shares | 152.6M | +4.7% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $10.3B · 113.8M shares | 113.8M | +0.7% |
| 3 | STATE STREET CORP | $7.3B · 80.9M shares | 80.9M | +1.7% |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5.4B · 59.7M shares | 59.7M | +31.2% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | $4.4B · 49M shares | 49M | +2.2% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $3.5B · 39.2M shares | 39.2M | +0.2% |
| 7 | Capital Research Global Investors | $3.3B · 36.9M shares | 36.9M | -25.8% |
| 8 | Capital International Investors | $3.1B · 34.7M shares | 34.7M | -7.6% |
| 9 | MORGAN STANLEY | $2.4B · 26.6M shares | 26.6M | -11.6% |
| 10 | NORGES BANK | $2.1B · 23.4M shares | 23.4M | — |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of ABT file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Apr 29, 2026 | VANGUARD CAPITAL MANAGEMENT LLC13G · passive | 7.5% |
| Mar 26, 2026 | VANGUARD GROUP INC13G · passive · amended | 0%under 5% |
Get the Full Analysis for ABT
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.